JPRN-UMIN000051198招募中Unknown
A double-blind, randomized controlled trial study on the preventive effect of cetylpyridinium chloride containing mouthwash on gingivitis during orthodontic treatment - Verification of the preventive effect of cetylpyridinium chloride-containing mouthwash on gingivitis during orthodontic treatment
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 40years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Subjects with congenital anomalies such as cleft lip and palate 2. Subjects with diseases such as gingivitis and caries 3. Subjects with systemic diseases or medications that interfere with treatment 4. Subjects who habitually use mouthwash 5. Others who are deemed inappropriate by the principal investigator or co-investigator
研究者
相似试验
已完成
不适用
A randomized, double-blind controlled trial study comparing the efficacy of granisetron versus lidocaine injection of trigger points in upper trapezius of patients with Myofascial Pain Syndrome referring to the AJA University Hospitalneck and upper trapezius pain.MyalgiaM79.1IRCT20200114046128N1Artesh University of Medical Sciences40
尚未招募
1 期
Pharmacokinetics (PK) and pharmacodynamics (PD) study of InsuBiomm R (Regular Insulin) in comparison to Humulin R in Type 1 patientsC18.452.394.750.124Type 1 diabetes mellitusRBR-7mvgfcInstituto de Ciências Farmacêuticas de Estudos e Pesquisas Ltda.
进行中（未招募）
1 期
A controlled, double-blind and randomized study, to compare the immunogenicity and safety of HEXAVAC manufactured by an upgraded process to HEXAVAC manufactured by the current process when given to healthy infants at 2, 4 & 6 months of age followed by a booster dose at 12 months of ageThe vaccine is indicated for primary and booster vaccination of children against six infectious diseases: diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis caused by 3 types of poliovirus (type 1,2 and 3), and invasive infections caused by Haemophilus influenza type b.EUCTR2005-002578-31-CZSanofi Pasteur MSD S.N.C.800
进行中（未招募）
1 期
A controlled, double-blind and randomized study, to compare the immunogenicity and safety of HEXAVAC manufactured by an upgraded process to HEXAVAC manufactured by the current process when given to healthy infants at 2, 4 & 6 months of age followed by a booster dose at 12 months of ageThe vaccine is indicated for primary and booster vaccination of children against six infectious diseases: diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis caused by 3 types of poliovirus (type 1,2 and 3), and invasive infections caused by Haemophilus influenza type b.EUCTR2005-002578-31-SKSanofi Pasteur MSD S.N.C.800
已完成
2 期
A study to evaluate, safety and efficacy of probiotic Unique IS2 in adults suffering from Irritable bowel syndrome in comparison with placebo.CTRI/2017/07/009170nique Biotech Limited136